105 related articles for article (PubMed ID: 32553686)
1. E3 ligase STUB1 attenuates stemness and tumorigenicity of oral carcinoma cells via transglutaminase 2 regulation.
Liu CM; Yu CC; Lin T; Liao YW; Hsieh PL; Yu CH; Lee SS
J Formos Med Assoc; 2020 Oct; 119(10):1532-1538. PubMed ID: 32553686
[TBL] [Abstract][Full Text] [Related]
2. E3 ligase carboxyl-terminus of Hsp70-interacting protein (CHIP) suppresses fibrotic properties in oral mucosa.
Chen SC; Liu CM; Hsieh PL; Liao YW; Lin YJ; Yu CC; Yu CH
J Formos Med Assoc; 2020 Feb; 119(2):595-600. PubMed ID: 31653576
[TBL] [Abstract][Full Text] [Related]
3. Transglutaminase 2 Regulates Self-renewal and Stem Cell Marker of Human Colorectal Cancer Stem Cells.
Kang S; Oh SC; Min BW; Lee DH
Anticancer Res; 2018 Feb; 38(2):787-794. PubMed ID: 29374703
[TBL] [Abstract][Full Text] [Related]
4. Loss of the Nuclear Pool of Ubiquitin Ligase CHIP/STUB1 in Breast Cancer Unleashes the MZF1-Cathepsin Pro-oncogenic Program.
Luan H; Mohapatra B; Bielecki TA; Mushtaq I; Mirza S; Jennings TA; Clubb RJ; An W; Ahmed D; El-Ansari R; Storck MD; Mishra NK; Guda C; Sheinin YM; Meza JL; Raja S; Rakha EA; Band V; Band H
Cancer Res; 2018 May; 78(10):2524-2535. PubMed ID: 29510992
[TBL] [Abstract][Full Text] [Related]
5. Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma.
Lin CS; Lin YC; Adebayo BO; Wu A; Chen JH; Peng YJ; Cheng MF; Lee WH; Hsiao M; Chao TY; Yeh CT
Cancer Lett; 2015 Nov; 368(1):36-45. PubMed ID: 26184998
[TBL] [Abstract][Full Text] [Related]
6. STUB1/CHIP: New insights in cancer and immunity.
Liu Y; Zhou H; Tang X
Biomed Pharmacother; 2023 Sep; 165():115190. PubMed ID: 37506582
[TBL] [Abstract][Full Text] [Related]
7. The ubiquitin ligase STUB1 suppresses tumorigenesis of renal cell carcinomas through regulating YTHDF1 stability.
Ma S; Sun Y; Gao G; Zeng J; Chen K; Zhao Z
Carcinogenesis; 2024 May; ():. PubMed ID: 38795009
[TBL] [Abstract][Full Text] [Related]
8. Transglutaminase 2 is upregulated in primary hepatocellular carcinoma with early recurrence as determined by proteomic profiles.
Yamaguchi H; Kuroda K; Sugitani M; Takayama T; Hasegawa K; Esumi M
Int J Oncol; 2017 May; 50(5):1749-1759. PubMed ID: 28339069
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of TGM2 with ITGB1 and SDC4 is important in the development and metastasis of renal cell carcinoma.
Erdem M; Erdem S; Sanli O; Sak H; Kilicaslan I; Sahin F; Telci D
Urol Oncol; 2014 Jan; 32(1):25.e13-20. PubMed ID: 23499501
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA‑214 suppresses the viability, migration and invasion of human colorectal carcinoma cells via targeting transglutaminase 2.
Shan H; Zhou X; Chen C
Mol Med Rep; 2019 Aug; 20(2):1459-1467. PubMed ID: 31173203
[TBL] [Abstract][Full Text] [Related]
11. CHIP/Stub1 functions as a tumor suppressor and represses NF-κB-mediated signaling in colorectal cancer.
Wang Y; Ren F; Wang Y; Feng Y; Wang D; Jia B; Qiu Y; Wang S; Yu J; Sung JJ; Xu J; Zeps N; Chang Z
Carcinogenesis; 2014 May; 35(5):983-91. PubMed ID: 24302614
[TBL] [Abstract][Full Text] [Related]
12. STUB1 regulates TFEB-induced autophagy-lysosome pathway.
Sha Y; Rao L; Settembre C; Ballabio A; Eissa NT
EMBO J; 2017 Sep; 36(17):2544-2552. PubMed ID: 28754656
[TBL] [Abstract][Full Text] [Related]
13. E3 Ubiquitin Ligases as Molecular Targets in Human Oral Cancers.
Masumoto K; Kitagawa M
Curr Cancer Drug Targets; 2016; 16(2):130-5. PubMed ID: 26560119
[TBL] [Abstract][Full Text] [Related]
14. Let-7c restores radiosensitivity and chemosensitivity and impairs stemness in oral cancer cells through inhibiting interleukin-8.
Peng CY; Wang TY; Lee SS; Hsieh PL; Liao YW; Tsai LL; Fang CY; Yu CC; Hsieh CS
J Oral Pathol Med; 2018 Jul; 47(6):590-597. PubMed ID: 29582468
[TBL] [Abstract][Full Text] [Related]
15. Transcription factor RFX1 is ubiquitinated by E3 ligase STUB1 in systemic lupus erythematosus.
Guo Y; Zhao M; Lu Q
Clin Immunol; 2016 Aug; 169():1-7. PubMed ID: 27283392
[TBL] [Abstract][Full Text] [Related]
16. The E3 ubiquitin ligase SIAH2 is a prosurvival factor overexpressed in oral cancer.
Hsieh SC; Kuo SN; Zheng YH; Tsai MH; Lin YS; Lin JH
Anticancer Res; 2013 Nov; 33(11):4965-73. PubMed ID: 24222137
[TBL] [Abstract][Full Text] [Related]
17. CD47-SIRPα Signaling Induces Epithelial-Mesenchymal Transition and Cancer Stemness and Links to a Poor Prognosis in Patients with Oral Squamous Cell Carcinoma.
Pai S; Bamodu OA; Lin YK; Lin CS; Chu PY; Chien MH; Wang LS; Hsiao M; Yeh CT; Tsai JT
Cells; 2019 Dec; 8(12):. PubMed ID: 31861233
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitin ligase STUB1 destabilizes IFNγ-receptor complex to suppress tumor IFNγ signaling.
Apriamashvili G; Vredevoogd DW; Krijgsman O; Bleijerveld OB; Ligtenberg MA; de Bruijn B; Boshuizen J; Traets JJH; D'Empaire Altimari D; van Vliet A; Lin CP; Visser NL; Londino JD; Sanchez-Hodge R; Oswalt LE; Altinok S; Schisler JC; Altelaar M; Peeper DS
Nat Commun; 2022 Apr; 13(1):1923. PubMed ID: 35395848
[TBL] [Abstract][Full Text] [Related]
19. GLI3 knockdown decreases stemness, cell proliferation and invasion in oral squamous cell carcinoma.
Rodrigues MFSD; Miguita L; De Andrade NP; Heguedusch D; Rodini CO; Moyses RA; Toporcov TN; Gama RR; Tajara EE; Nunes FD
Int J Oncol; 2018 Dec; 53(6):2458-2472. PubMed ID: 30272273
[TBL] [Abstract][Full Text] [Related]
20. Dishevelled-3 phosphorylation is governed by HIPK2/PP1Cα/ITCH axis and the non-phosphorylated form promotes cancer stemness via LGR5 in hepatocellular carcinoma.
Tsui YM; Sze KM; Tung EK; Ho DW; Lee TK; Ng IO
Oncotarget; 2017 Jun; 8(24):39430-39442. PubMed ID: 28455968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
